Gout drug Colchicine to be tested as COVID-19 treatment | Daily Mail Online
Colchicine, a gout treatment, is being tested in the RECOVERY trial for COVID-19 due to its anti-inflammatory effects. The trial, led by Oxford University, aims to determine if colchicine can reduce death risk in hospitalized patients. It's part of the world's largest COVID-19 treatment trial, which previously found dexamethasone effective for severe cases.
Reference News
Gout drug Colchicine to be tested as COVID-19 treatment | Daily Mail Online
Colchicine, a gout treatment, is being tested in the RECOVERY trial for COVID-19 due to its anti-inflammatory effects. The trial, led by Oxford University, aims to determine if colchicine can reduce death risk in hospitalized patients. It's part of the world's largest COVID-19 treatment trial, which previously found dexamethasone effective for severe cases.